Analysis of patterns of bacteremia and 30-day mortality in patients with acute cholangitis over a 25-year period

References

• Lee JG. Diagnosis and management of acute cholangitis. Nat Rev Gastroenterol Hepatol. 2009;6(9):533–541.
   PubMed Web of Science ®Google Scholar
• Lee F, Ohanian E, Rheem J, et al. Delayed endoscopic retrograde cholangiopancreatography is associated with persistent organ failure in hospitalised patients with acute cholangitis. Aliment Pharmacol Ther. 2015;42(2):212–220.
   PubMed Web of Science ®Google Scholar
• Tan M, Schaffalitzky de Muckadell OB, Laursen SB. Association between early ERCP and mortality in patients with acute cholangitis. Gastrointest Endosc. 2018;87(1):185–192.
   PubMed Web of Science ®Google Scholar
• Karvellas CJ, Abraldes JG, Zepeda-Gomez S, et al. The impact of delayed biliary decompression and anti-microbial therapy in 260 patients with cholangitis-associated septic shock. Aliment Pharmacol Ther. 2016;44(7):755–766.
   PubMed Web of Science ®Google Scholar
• Ispahani P, Pearson NJ, Greenwood D. An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. Quar J Med. 1987;63(241):427–440.
   PubMedGoogle Scholar
• Pedersen G, Schønheyder HC, Sørensen HT. Source of infection and other factors associated with case fatality in community-acquired bacteremia-a Danish population-based cohort study from 1992 to 1997. Clin Microbiol Infect. 2003;9(8):793–802.
   PubMed Web of Science ®Google Scholar
• Sokal A, Sauvanet A, Fantin B, et al. Acute cholangitis: diagnosis and management. J Visc Surg. 2019;156(6):515–525.
   PubMed Web of Science ®Google Scholar
• Englesbe MJ, Dawes LG. Resistant pathogens in biliary obstruction: importance of cultures to guide antibiotic therapy. HPB. 2005;7(2):144–148.
   PubMedGoogle Scholar
• Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25(1):3–16.
   PubMed Web of Science ®Google Scholar
• Tagashira Y, Sakamoto N, Isogai T, et al. Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study. Clin Microbiol Infect. 2017;23(10):740–747.
   PubMed Web of Science ®Google Scholar
• Goo JC, Seong MH, Shim YK, et al. Extended spectrum-β-lactamase or carbapenemase producing bacteria isolated from patients with acute cholangitis. Clin Endosc. 2012;45(2):155–160.
   PubMedGoogle Scholar
• Sung YK, Lee JK, Lee KH, et al. The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens. Am J Gastroenterol. 2012;107(3):473–483.
   PubMed Web of Science ®Google Scholar
• Lee CC, Chang IJ, Lai YC, et al. Epidemiology and prognostic determinants of patients with bacteremic cholecystitis or cholangitis. Am J Gastroenterol. 2007;102(3):563–569.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Wada K, Takada T, Kawarada Y, et al. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007;14(1):52–58.
   PubMedGoogle Scholar
• Takada T, Strasberg SM, Solomkin JS, et al. TG13: updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013;20(1):1–7.
   PubMed Web of Science ®Google Scholar
• Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):17–30.
   PubMed Web of Science ®Google Scholar
• Lee BS, Hwang JH, Lee SH, Jang SE, Jang ES, et al. Risk factors of organ failure in patients with bacteremic cholangitis. Dig Dis Sci. 2013;58(4):1091–1099.
   PubMed Web of Science ®Google Scholar
• Jean SS, Hsueh PR. Antimicrobial susceptibilities of the Ertapenem-non-susceptible Non-carbapenemase-producing enterobacterales isolates causing intra-abdominal infections in the Asia-Pacific Region during 2008–2014: results from the Study for Monitoring the Antimicrobial Resistance Trends (SMART). J Glob Antimicrob Resist. 2020;21:91–98.
   PubMed Web of Science ®Google Scholar
• Lob SH, Nicolle LE, Hoban DJ, et al. Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010–2014. Diagn Microbiol Infect Dis. 2016;85(4):459–465.
   PubMed Web of Science ®Google Scholar
• Lob SH, Biedenbach DJ, Badal RE, et al. Antimicrobial resistance and resistance mechanisms of Enterobacteriaceae in ICU and non-ICU wards in Europe and North America: SMART 2011–2013. J Glob Antimicrob Resist. 2015;3(3):190–197.
   PubMed Web of Science ®Google Scholar
• Molstad S, Lofmark S, Carlin K, et al. Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance. Bull World Health Organ. 2017;95(11):764–773.
   PubMed Web of Science ®Google Scholar
• Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet. 2001;357(9271):1851–1853.
   PubMed Web of Science ®Google Scholar
• Reuken PA, Torres D, Baier M, et al. Risk factors for multi-drug resistant pathogens and failure of empiric first-line therapy in acute cholangitis. PLoS One. 2017;12(1):e0169900.
   PubMed Web of Science ®Google Scholar
• Harris PNA, Tambyah PA, Lye DC, et al. Effect of piperacillin-Tazobactam vs Meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA. 2018;320(10):984–994.
   PubMed Web of Science ®Google Scholar
• Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 2008;13(47):19044.
   PubMedGoogle Scholar
• Richelsen R, Smit J, Anru PL, et al. Incidence of community-onset extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae infections: an 11-year population-based study in Denmark. Infect Dis. 2020;52(8):547–556.
   PubMed Web of Science ®Google Scholar
• Hansen DS, Schumacher H, Hansen F, et al. Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, β-lactamase distribution, phylogroups, and co-resistance. Scand J Infect Dis. 2012;44(3):174–181.
   PubMed Web of Science ®Google Scholar
• Tan M, Schaffalitzky de Muckadell OB, Laursen SB. Unchanged mortality in patients with acute cholangitis despite an increase in malignant etiologies – a 25-year epidemiological study. Scand J Gastroenterol. 2019;54(3):335–341.
   PubMed Web of Science ®Google Scholar
• Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):31–40.
   PubMed Web of Science ®Google Scholar
• Mosler P. Diagnosis and management of acute cholangitis. Curr Gastroenterol Rep. 2011;13(2):166–172.
   PubMedGoogle Scholar
• Iqbal U, Khara H, Hu Y, et al. Emergent versus urgent ERCP in acute cholangitis: a systematic review and meta-analysis. Gastrointest Endosc. 2019;91(4):753–760.e4.
   PubMed Web of Science ®Google Scholar
• Andersen TF, Madsen M, Jorgensen J, et al. The Danish national hospital register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263–268.
   PubMed Web of Science ®Google Scholar